Amber Medical For Profit

Scientific Breakthrough: Long-term prevention of thrombosis without DAPT! Each year, millions of patients worldwide undergo coronary stenting to treat ischemic heart disease. While drug-eluting stents, in comparison with bare-metal stents, reduce the rate of restenosis, there is concern that they are associated with a risk, starting one year after treatment, of stent thrombosis – a …

Headquarters: Jerusalem, Yerushalayim, Israel
Estimated Revenue: $3 million
Technology: Drug delivery
Founded Date: 2016-06-01
Industry: PharmTech